Niki BioSolutions, Inc. (NIKI) Gross margin 2023–2025
Niki BioSolutions, Inc. (NIKI) gross margin by fiscal year — reported gross profit divided by reported revenue.
2.4%FY2025 · since FY2023: 5.3% → 2.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 2.4% | -3.7 pp |
| FY2024 | 6.2% | +0.9 pp |
| FY2023 | 5.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More NIKI financial trends
NIKI RevenueNIKI Net incomeNIKI Net marginNIKI Gross profitNIKI Operating incomeNIKI Operating marginNIKI Operating cash flowNIKI Free cash flowNIKI Capital expendituresNIKI Return on equityNIKI Stock buybacksNIKI Dividends paidNIKI Total assetsNIKI Total liabilitiesNIKI Shareholders’ equityNIKI overview →